Lv1
90 积分 2024-10-05 加入
Hetero-bivalent agents targeting FAP and PSMA
2天前
已完结
Design, preclinical evaluation, and first-in-human PET study of [68Ga]Ga-PSFA-01: a PSMA/FAP heterobivalent tracer
3天前
已完结
Design, synthesis, and preclinical evaluation of a novel bifunctional macrocyclic chelator for theranostics of cancers
1个月前
已完结
A step closer to the use of [(177)Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer
1个月前
已完结
Molecular Evolution of Multivalent OncoFAP Derivatives with Enhanced Tumor Uptake and Prolonged Tumor Retention
1个月前
已完结
Lutetium177-Labeled DOTA-Ibandronate: A Novel Radiopharmaceutical for Targeted Treatment of Bone Metastases
1个月前
已完结
Preclinical Evaluation of177Lu-OncoFAP-23, a Multivalent FAP-Targeted Radiopharmaceutical Therapeutic for Solid Tumors
1个月前
已完结
皖公网安备34019202002308
